Focus: AVITA Medical is a medical device company specializing in autologous skin cell harvesting and treatment devices for dermatological conditions, particularly burns and chronic wounds. The company operates in the specialized biotech/medtech segment with a focused therapeutic portfolio.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
7 added, 6 removed. Backfill posture.
Best suited for candidates seeking niche device-company experience in dermatology with established commercialization; growth and hiring limitations present career-progression constraints.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for AVITA Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from AVITA Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
+2 more
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Tenaya Therapeutics (TNYA) and Elevance Health (ELV) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Tenaya Therapeutics (TNYA) and Elevance Health (ELV) The Globe and Mail
ASX Health Care Stocks With Buy Ratings Investors Are Watching Now - Kalkine
ASX Health Care Stocks With Buy Ratings Investors Are Watching Now Kalkine
Health Check: Investors are wide awake for Avecho’s pending insomnia trial results - stockhead.com.au
Health Check: Investors are wide awake for Avecho’s pending insomnia trial results stockhead.com.au
Island shares soar on Ebola drug hopes - The Mercury
Island shares soar on Ebola drug hopes The Mercury
Island shares soar on Ebola drug hopes - NT News
Island shares soar on Ebola drug hopes NT News
Avita Medical (RCEL) Q1 Loss Of US$0.35 Per Share Tests Profitability Optimism - simplywall.st
Avita Medical (RCEL) Q1 Loss Of US$0.35 Per Share Tests Profitability Optimism simplywall.st
Showing 6 of 10 news items
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles